Analysts expect Aquestive Therapeutics, Inc. to report revenue of 12.32 M for Q4 26, against a range of 11.61 M to 13.03 M. The most recent reported quarter, Q3 26, came in at 7.56 M, a 33.7% miss against the 11.41 M consensus.
| Metric | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 11.87 M | 8.72 M | 10.00 M | 12.81 M | 13.02 M | 14.45 M | 13.82 M | 7.56 M | - | - | - | - | - | - | - | - | |||||||||
| High Estimate | 13.33 M | 13.63 M | 11.45 M | 13.04 M | 14.43 M | 10.97 M | 12.94 M | 11.96 M | 13.03 M | 12.95 M | 15.80 M | 17.51 M | 18.33 M | 25.71 M | 25.61 M | 31.33 M | |||||||||
| Low Estimate | 12.09 M | 12.05 M | 10.30 M | 11.71 M | 13.13 M | 10.25 M | 11.09 M | 10.85 M | 11.61 M | 11.12 M | 13.11 M | 15.81 M | 15.68 M | 21.11 M | 22.61 M | 26.17 M | |||||||||
| Consensus Estimate | 12.71 M | 12.84 M | 10.87 M | 12.37 M | 13.78 M | 10.61 M | 12.02 M | 11.41 M | 12.32 M | 12.04 M | 14.46 M | 16.66 M | 17.01 M | 23.41 M | 24.11 M | 28.75 M |
Analysts expect Aquestive Therapeutics, Inc. to report earnings per share of -0.14 for Q4 26, against a range of -0.15 to -0.13. The most recent reported quarter, Q3 26, came in at -0.13, a 18.2% miss against the -0.11 consensus.
| Metric | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.19 | -0.24 | -0.14 | -0.14 | -0.26 | -0.07 | -0.18 | -0.13 | - | - | - | - | - | - | - | - | |||||||||
| High Estimate | -0.12 | -0.15 | -0.16 | -0.11 | -0.12 | -0.11 | -0.09 | -0.10 | -0.13 | -0.11 | -0.11 | -0.11 | -0.12 | -0.06 | -0.08 | -0.07 | |||||||||
| Low Estimate | -0.14 | -0.17 | -0.20 | -0.13 | -0.14 | -0.13 | -0.11 | -0.12 | -0.15 | -0.13 | -0.13 | -0.13 | -0.14 | -0.08 | -0.10 | -0.09 | |||||||||
| Consensus Estimate | -0.13 | -0.16 | -0.18 | -0.12 | -0.13 | -0.12 | -0.10 | -0.11 | -0.14 | -0.12 | -0.12 | -0.12 | -0.13 | -0.07 | -0.09 | -0.08 |
Pull Wall Street consensus for Aquestive Therapeutics, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=AQST&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "AQST", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=AQST&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();